HEV-specific antiviral treatment is still lacking. Here, the authors functionally and structurally characterize broadly neutralizing antibodies isolated from HEV convalescent individuals and show that they have protective effects in human liver-chimeric mice infected with HEV.
- George Ssebyatika
- Katja Dinkelborg
- Patrick Behrendt
